Report on Cardiovascular Health and Diseases in China 2023:an Updated Summary
10.3969/j.issn.1000-3614.2024.07.001
- VernacularTitle:中国心血管健康与疾病报告2023概要
- Author:
National Center for Cardiovascular Diseases
;
The Writing Committee of the Report on Cardiovascular Health and Diseases in China
;
Shengshou HU
- Keywords:
cardiovascular disease;
risk factor;
prevalence;
mortality;
rehabilitation;
basic research;
medical device development;
health economics
- From:
Chinese Circulation Journal
2024;39(7):625-660
- CountryChina
- Language:Chinese
-
Abstract:
Since 1990,significant progress has been achieved on solving the problem of"treatment difficulty"of cardiovascular diseases(CVD)in China.There are huge population with CVD risk factors due to the prevalent unhealthy lifestyle among Chinese residents,this situation is further worsened due to accelerated aging of the population in China.CVD remains one of the greatest threats to the health of Chinese residents.In terms of proportions of disease mortality among urban and rural residents in China,CVD still ranks the first.In 2021,CVD accounted for 48.98%and 47.35%of deaths in rural and urban areas,respectively.Two out of every five deaths are due to CVD.In order to implement the national policy of"focusing on the primary health institute and emphasizing prevention"and truly achieve the shift of the CVD prevention and treatment from hospitals to communities,the National Center for Cardiovascular Diseases has organized experts from relevant fields across the country to compile the"Report on Cardiovascular Health and Diseases in China"annually since 2005.This year's report is established based on representative,published,and high-quality big-data research results from cross-sectional and cohort population epidemiological surveys,randomized controlled clinical studies,large sample registry studies,and typical community prevention and treatment cases,present report also includes data from some of the projects undertaken by the National Center for Cardiovascular Diseases.These first hand data not only enrich the content of the current report but also provide a more timely and comprehensive reflection of the status of CVD prevention and treatment in China.
